Follow The Filings

NSPR InspireMD

InspireMD earnings company data as of 8:01 PM ET 10/22

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 3 Nov EPS — — —
Rev — — —
FY2026 Q2 14 Aug EPS — -0.17 —
Rev — $1.8M —

Insider trades

Open-market buys and sales by NSPR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NSPR insider trades
  • $421K bought by 4 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Paul Stuka Director
    Buy
    $18K 20,000 shares at $0.8800 +3.1% to stake
    Traded May 27 Filed May 29
  2. Paul Stuka Director
    Buy
    $17K 15,000 shares at $1.16 +2.4% to stake
    Traded May 13–14 Filed May 15
  3. Marvin Slosman CEO
    Buy
    $25K 21,000 shares at $1.20 +0.6% to stake
    Traded May 12 Filed May 13
  4. Paul Stuka Director
    Buy
    $88K 75,626 shares at $1.16 +14% to stake
    Traded May 8–11 Filed May 13
  5. Scott R. Ward Director
    Buy
    $103K 89,250 shares at $1.15 +60% to stake
    Traded May 6–7 Filed May 8
  6. Paul Stuka Director
    Buy
    $9,034 7,895 shares at $1.14 +1.5% to stake
    Traded May 6–7 Filed May 8
  7. Gary S Roubin Director
    Buy
    $106K 90,000 shares at $1.18 +12% to stake
    Traded May 7 Filed May 8
  8. Paul Stuka Director
    Buy
    $4,905 2,710 shares at $1.81 +0.7% to stake
    Traded Dec 9, 2025 Filed Feb 23
  9. Paul Stuka Director
    Buy
    $9,436 5,073 shares at $1.86 +1.3% to stake
    Traded Dec 5, 2025 Filed Dec 8, 2025
  10. Paul Stuka Director
    Buy
    $19K 10,130 shares at $1.85 +2.7% to stake
    Traded Dec 4, 2025 Filed Dec 5, 2025
  11. Paul Stuka Director
    Buy
    $22K 13,431 shares at $1.62 +3.7% to stake
    Traded Nov 12, 2025 Filed Nov 13, 2025

Also filed in the last 12 months, not counted as buying or selling: 12 sales to cover taxes and 11 stock grants.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 1.01,3.02,7.01,9.01
8-K 2.02,9.01
10-Q
8-K 5.02,9.01
8-K 3.01,9.01
8-K 5.02,9.01
8-K 7.01,9.01
8-K 5.03,5.07,9.01
8-K 5.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
8-K 7.01,8.01,9.01
SCHEDULE 13D —
DEFA14A
DEF 14A
DEFA14A
424B5
8-K 1.01,8.01,9.01
8-K 2.02,7.01,9.01
10-K
8-K 5.02,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.